May 18, 2004Open Access

Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis

Key Points

Key points are not available for this paper at this time.

Abstract

OPG and OPN are upregulated in symptomatic human carotid atherosclerosis with possible implications for plaque stability. Angiotensin II blockade is able to downregulate OPG secretion in vitro.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Golledge et al. (Tue,) studied this question.

synapsesocial.com/papers/69dabfa1387cf706986879e3 https://doi.org/https://doi.org/10.1161/01.str.0000129790.00318.a3

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Enzymatic Determination of Total Serum Cholesterol1974 · 9,177 citations
2Serum kreatininbestimmung ohne enteiweissen1972 · 799 citations
3RANK Ligand and Osteoprotegerin2002 · 402 citations
4Influence of patient-related variables on the outcome of carotid endarterectomy1996 · 92 citations
5Osteopontin Inhibits Mineral Deposition and Promotes Regression of Ectopic Calcification2002 · 418 citations

Demander à l'IA

Bookmark

View Full Paper